Asthma in pregnancy

Obstetrics and Gynecology Clinics of North America

Volumn 31, Issue 2, 2004, Pages 385-413

  Gardner, Michael O ^a,b   Doyle, Nora M ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BEN TAUB GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIINFLAMMATORY AGENT; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; INFLUENZA VACCINE; IPRATROPIUM BROMIDE; MONOCLONAL ANTIBODY; MONTELUKAST; NEDOCROMIL; OMALIZUMAB; ORCIPRENALINE; PREDNISONE; SALBUTAMOL; SALMETEROL; STEROID; TERBUTALINE; THEOPHYLLINE; UNINDEXED DRUG; ZAFIRLUKAST;

AIR CONDITIONING; ALLERGY; ANAPHYLAXIS; ASTHMA; BREAST FEEDING; CARDIOTOXICITY; DISEASE SEVERITY; DRUG RESPONSE; EXERCISE; FETUS DEATH; FETUS MORTALITY; FETUS OUTCOME; FLOWMETER; FUNCTIONAL ANATOMY; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERTENSION; IMMUNOTHERAPY; IRRITABILITY; LUNG CAPACITY; LUNG FUNCTION; MATERNAL HYPERTENSION; NAUSEA; PATHOPHYSIOLOGY; PATIENT EDUCATION; PATIENT MONITORING; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; PUERPERIUM; RESPIRATION DEPRESSION; REVIEW; SIDE EFFECT; WAKEFULNESS;

ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 2942559075     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2004.03.010     Document Type: Review

References (38)

1. NAEPP Report J Allergy Clin Immunol. 110:2002;S142-S183
2. Rosenwasser L.J., Nash D.B. Incorporating omalizumab into asthma treatment guidelines: Consensus Panel Recommendations. Pharmacy and Therapeutics. 28:2003;400-414
3. Liu S., Wen S.W., Demissie K., et al. Maternal asthma and pregnancy outcomes: a retrospective cohort study. Am J Obstet Gynecol. 184:2001;90-96
4. Kwon H., Belanger K., Bracken M. Asthma prevalence during pregnancy in the United States: estimates from national health surveys. Ann Epidemiol. 13:2003;317-324
5. Weinberger S.E., Weiss S.T. Pulmonary diseases. Burrow G.N., Ferris T.F. Medical complications during pregnancy. 4th edition:1995;446-455 WB Saunders, Philadelphia
6. Dombrowski M.P., Schatz M., Wise R., et al. Asthma during pregnancy. Obstet Gynecol. 103:2004;5-12
7. Bracken M.B., Triche E.W., Belanger K., et al. Asthma symptoms, seveity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol. 102:2003;739-752
8. National Heart, Lung, and Blood Institute. National Asthma Education Program. Working Group on Asthma and Pregnancy Management of asthma during pregnancy: executive summary: report of the Working Group on Asthma and Pregnancy. NIH Publication no. 93-3279A. 1993;NAEP, NHLBI, National Institutes of Health, Bethesda, Maryland
9. Tan K.S., Thomson N.C. Asthma in pregnancy. Am J Med. 109:2000;727-733
10. O'Day M.P. Cardio-respiratory physiological adaptation of pregnancy. Semin Perinatol. 21:1997;268-275
11. Witlin A.G. Asthma in pregnancy. Semin Perinatol. 21:1997;284-297
12. De Swiet M. Pulmonary disorders. Creasy R.K., Resnik R. Maternal-fetal medicine. 4th edition:1999;921-934 WB Saunders, Philadelphia
13. Prowse G.B., Gaensler E.A. Respiratory and acid-base changes during pregnancy. Anesthesiology. 26:1965;381-392
14. Wendel P.J. Asthma in pregnancy. Obstet Gynecol Clin North Am. 28:2001;537-551
15. Nafstad P., Samuelsen S.O., Irgens L.M., et al. Pregnancy complications and the risk of asthma among Norwegians born between 1967 and 1993. Eur J Epidemiol. 18:2003;755-761
16. Lawrence R.A., Lawrence R.M. Breastfeeding a guide for the medical profession. 5th edition:1999;Mosby, St. Louis (MO)
17. Williams D.A. Asthma and pregnancy. Acta Allergol. 22:1967;311-323
18. Gluck J.C., Gluck P.A. The effects of pregnancy on asthma: a prospective study. Ann Allergy. 37:1976;164-168
19. Gazioglu K., Kaltreider N.L., Rosen M., et al. Pulmonary function during pregnancy in normal women and patients with cardiopulmonary disease. Thorax. 25:1970;445-450
20. Clark S.L. National Asthma Education Program Working Group on Asthma and Pregnancy. National Institutes of Health, National Heart, Lung and Blood Institute Asthma in pregnancy. Obstet Gynecol. 82:1993;1036-1041
21. Liccardi G., Cazzola M., Canonica G.W., et al. General strategy for the management of bronchial asthma in pregnancy. Respir Med. 97:2003;778-789
22. Schatz M. Asthma and pregnancy. Lancet. 353:1999;1202-1204
23. Schatz M., Zeiger R.S., Hoffman G.P., et al. Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis. Am J Respir Crit Care Med. 151:1995;1170-1174
24. Perlow J.H., Montogomery D., Morgan M.A., et al. Severity of asthma and perinatal outcome. Am J Obstet Gynecol. 167:1992;963-967
25. National Institutes of Health, National Heart, Lung and Blood Institute Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report. 1993;. Publication #NIH 95-3659
26. Pulmonary disease in pregnancy. ACOG Tech Bull. 224:1996;738-742
27. American Lung Association Peak flow meters. 2004;American Lung Association. Available at: http://www.lungusa.org/asthma/astpeakflow.html. Accessed March 11, 2004
28. Canadian Lung Association Asthma provoking factors. 2003;Canadian Lung Association. Available at: http://www.lung.ca/asthma/provoke.html. Accessed February 2, 2004
29. Dombrowski M.P. Pharmacologic therapy of asthma during pregnancy. Obstet Gynecol Clin North Am. 24:1997;559-574
30. Woolcock A., Lundback B., Ringdal N., et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med. 153:1996;1481-1488
31. Hale T.W. Medications and mothers' milk. 10th edition:2002;Pharmasoft Publishing, Amarillo (TX)
32. Kallen B., Rydhstraem H., Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 93:1999;392-395
33. Robert E., Vollset S.E., Botto L., et al. Malformation surveillance and maternal drug exposure: the madre project. Int J Risk Safety Ed. 6:1994;75-118
34. Carmichael S.L., Shaw G.M. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet. 86:1999;242-244
35. Czeizel A.E., Rockenbauer M. Population-based case control study of teratogenic potential of corticosteroids. Teratology. 56:1997;335-340
36. Hernandez E., Angell C.S., Johnson J.W.C. Asthma in pregnancy:current concepts. Obstet Gynecol. 55:1980;739-743
37. Cunningham G.C., Gant N.F., Leveno K.J., et al. Medical and surgical complications in pregnancy. Williams obstetrics. 21st edition:2001;McGraw Hill, New York
38. Schatz M., Harden K., Forsythe A., et al. The course of asthma during pregnancy, postpartum and with successive pregnancies: a prospective analysis. J Allergy Clin Immunol. 81:1988;509-511